Theophylline

茶碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTheophylline
Drug Alias Name茶硷氨茶碱茶叶碱二甲基黄嘌呤Theo-Dur +[16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine receptor antagonists
TargetsAdenosine receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)DepressionAcute Kidney Injury +[17
Global Approved IndicationsPulmonary EmphysemaAsthmaBronchitis, Chronic
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryCanada
Original Approved Date1965/12/31
Country/TerritoryCanadaUnited StatesUganda +[6
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsCoronavirus Disease 2019 (COVID-19)Acute Kidney InjuryAgeusia +[9
Inactive IndicationsDepressionApneaRhinitis, Allergic +[8

Other Information

ATC CodeR03DA04